Alexander M. Sergeev
Corporate Officer/Principal chez Russian Academy of Sciences
Profil
Alexander M.
Sergeev is the founder of Imalux Corp.
which was founded in 1996.
He held the title of Director at Imalux Corp.
Dr. Sergeev's current job is Director-Lasers & Nonlinear Optics Division at Russian Academy of Sciences.
Postes actifs de Alexander M. Sergeev
| Sociétés | Poste | Début |
|---|---|---|
| Russian Academy of Sciences | Corporate Officer/Principal | 28/04/2009 |
Anciens postes connus de Alexander M. Sergeev
| Sociétés | Poste | Fin |
|---|---|---|
Imalux Corp.
 Imalux Corp. Medical SpecialtiesHealth Technology Imalux, the medical device company on a mission. They're leading the world in the development of Optical Coherence Tomography (OCT), a breakthrough medical imaging modality used to visualize tissue microstructure in real-time, at the site of patient care. With the Niris Imaging System, its first generation OCT solution, Imalux provides physicians and surgeons a valuable tissue-profiling tool to assist in the diagnosis, treatment, and surveillance of disease. Currently, clinicians do not have effective imaging methods for detecting tissue structure abnormalities in a timely manner and at the point-of-care. Physicians, therefore, must rely on prior imaging studies and visual findings to guide surgery and treatment. There exists an unmet need for real-time, high spatial resolution medical imaging that can be used in a wide range of applications and practice settings at a reasonable cost. Globally, the healthcare community is searching for ways to streamline the delivery of care without compromising clinical outcomes. The Imalux Niris Imaging System offers clinicians the ability to 'see and treat' in a single patient visit a single episode of care. Imalux is developing products and services to address this serious clinical need that cannot be satisfied by current technologies. In time, Imalux anticipates that Optical Coherence Tomography will take its place alongside x-ray, ultrasound, Magnetic Resonance Imaging (MRI), Computerized Axial Tomography (CT scans), and nuclear medicine as the 'sixth imaging modality.' At present, research efforts continue as Imalux conducts further studies to establish the value of OCT in clinical settings and lead to eventual commercialization of the technology. | Fondateur | 14/08/2009 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Imalux Corp.
Imalux Corp. Medical SpecialtiesHealth Technology Imalux, the medical device company on a mission. They're leading the world in the development of Optical Coherence Tomography (OCT), a breakthrough medical imaging modality used to visualize tissue microstructure in real-time, at the site of patient care. With the Niris Imaging System, its first generation OCT solution, Imalux provides physicians and surgeons a valuable tissue-profiling tool to assist in the diagnosis, treatment, and surveillance of disease. Currently, clinicians do not have effective imaging methods for detecting tissue structure abnormalities in a timely manner and at the point-of-care. Physicians, therefore, must rely on prior imaging studies and visual findings to guide surgery and treatment. There exists an unmet need for real-time, high spatial resolution medical imaging that can be used in a wide range of applications and practice settings at a reasonable cost. Globally, the healthcare community is searching for ways to streamline the delivery of care without compromising clinical outcomes. The Imalux Niris Imaging System offers clinicians the ability to 'see and treat' in a single patient visit a single episode of care. Imalux is developing products and services to address this serious clinical need that cannot be satisfied by current technologies. In time, Imalux anticipates that Optical Coherence Tomography will take its place alongside x-ray, ultrasound, Magnetic Resonance Imaging (MRI), Computerized Axial Tomography (CT scans), and nuclear medicine as the 'sixth imaging modality.' At present, research efforts continue as Imalux conducts further studies to establish the value of OCT in clinical settings and lead to eventual commercialization of the technology. | Health Technology |
